Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers

about

Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers

Item

http://www.wikidata.org/entity/Q58765839

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@en

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@nl

type

Item

label

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@en

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@nl

prefLabel

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@en

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@nl

P1476

Novel Compound Induces Erythro ...... atients and Healthy Volunteers

@en

P2093

Aya Shinfuku

http://www.w3.org/2001/XMLSchema#string

Fumihiko Sato

http://www.w3.org/2001/XMLSchema#string

Hironori Yamasaki

http://www.w3.org/2001/XMLSchema#string

Hirotaka Watase

http://www.w3.org/2001/XMLSchema#string

Jinsei Maruyama

http://www.w3.org/2001/XMLSchema#string

Masanori Fujiwara

http://www.w3.org/2001/XMLSchema#string

Masaru Mutoh

http://www.w3.org/2001/XMLSchema#string

Noriko Takayama

http://www.w3.org/2001/XMLSchema#string

Sota Kato

http://www.w3.org/2001/XMLSchema#string

Takumi Numazaki

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.

Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Increased Synthesis of Liver Erythropoietin with CKD.

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.

Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans.

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

Rapid detection of erythropoiesis-stimulating agents in urine and serum.

Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.

Erythropoietin mRNA expression in human fetal and neonatal tissue.

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000492181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30176654

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

Erythropoietin

P932

6214603

http://www.w3.org/2001/XMLSchema#string